HUMACYTE INC's ticker is and the CUSIP is 44486Q111. A total of 12 filers reported holding HUMACYTE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $154,876 | -15.3% | 262,457 | +4.8% | 0.00% | – |
| Q2 2023 | $182,834 | +27.3% | 250,457 | +4.6% | 0.00% | – |
| Q1 2023 | $143,674 | +63.6% | 239,457 | +7.1% | 0.00% | – |
| Q4 2022 | $87,807 | -58.8% | 223,656 | +15.5% | 0.00% | – |
| Q3 2022 | $213,000 | +25.3% | 193,656 | 0.0% | 0.00% | – |
| Q2 2022 | $170,000 | -50.3% | 193,656 | +29.3% | 0.00% | – |
| Q4 2021 | $342,000 | +293.1% | 149,792 | +399.3% | 0.00% | – |
| Q3 2021 | $87,000 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RPO LLC | 81,705 | $159,000 | 0.05% |
| CVI Holdings, LLC | 269,138 | $517,000 | 0.03% |
| Sio Capital Management, LLC | 49,998 | $97,000 | 0.03% |
| Alpine Global Management, LLC | 95,000 | $182,000 | 0.02% |
| Exos Asset Management LLC | 27,151 | $53,000 | 0.02% |
| TUDOR INVESTMENT CORP ET AL | 236,549 | $461,000 | 0.01% |
| LMR Partners LLP | 50,000 | $353,000 | 0.00% |
| P SCHOENFELD ASSET MANAGEMENT LP | 19,155 | $37,000 | 0.00% |
| Diameter Capital Partners LP | 19,085 | $37,000 | 0.00% |
| HRT FINANCIAL LP | 50,250 | $96,000 | 0.00% |